What is DexCom's R&D?

DexCom (DXCM) reported R&D of $153M in Q2 2026.

How has DexCom's R&D changed year-over-year?

DexCom's R&D increased by 3.2% year-over-year, from $148.2M to $153M.

What is the long-term trend for DexCom's R&D?

Over 4 years (2021 to 2025), DexCom's R&D has grown at a 3.7% compound annual growth rate (CAGR), from $517.1M to $599.1M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

DexCom DXCM R&D

R&D at other companies

Frequency ElectronicsFEIM

$1.9M+23.3%

SOL

SOLSSOLS

$28M+27.3%

Cabot CorporationCBT

$14M-6.7%

MillerKnollMLKN

$35.4M+46.3%

Iridium CommunicationsIRDM

$5.53M+29.2%

Spok HoldingsSPOK

$3.46M+11.7%

Other financials

Income statement

See full

Revenue$1.3B+13.1%

Gross profit$830.0M+20.5%

Operating income$318.3M+49.7%

Net income$249.1M+38.5%

EPS (diluted)$0.64+42.2%

Balance sheet

See full

Cash & equivalents$1.1B-4.8%

Total debt$103.3M-23.1%

Total equity$2.6B+1.9%

Total assets$6.5B-11.9%

Cash flow

See full

Operating cash flow$525.6M+186%

CapEx$76.6M-12.0%

Free cash flow$449.0M+364%

Valuation

See full

Market cap$28.88B-17.0%

Enterprise value$27.88B-17.4%

P/E28.9×-32.0×

P/S5.8×-2.3×

Profitability

See full

Gross margin62.5%+3.7pp

Operating margin22.9%+6.9pp

Net margin20.1%+6.8pp

FCF margin29.7%+15.8pp

Returns & leverage

See full

Return on equity38.5%+15.7pp

Debt / equity0×0.0×

Current ratio1.7×+0.2×

Where this comes from

Reported directly by DexCom in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: DexCom’s 8-K, filed July 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about DexCom's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is DexCom's R&D?: DexCom (DXCM) reported R&D of $153M in Q2 2026.
How has DexCom's R&D changed year-over-year?: DexCom's R&D increased by 3.2% year-over-year, from $148.2M to $153M.
What is the long-term trend for DexCom's R&D?: Over 4 years (2021 to 2025), DexCom's R&D has grown at a 3.7% compound annual growth rate (CAGR), from $517.1M to $599.1M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.